Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Number of holders
-
59
-
Total 13F principal, excl. options
-
559,810,772
-
Principal change
-
-13,614,138
-
Total reported value, excl. options
-
$663,662,866
-
Value change
-
-$31,257,430
-
Number of buys
-
29
-
Number of sells
-
-26
-
Price
-
$1.18
Significant Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q2 2019
71 filings reported holding 464337AJ3 - ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q2 2019.
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 has 59 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $559,810,772 of principal
.
Largest 10 bondholders include STEELHEAD PARTNERS LLC ($52,496,000 of principal), CALAMOS ADVISORS LLC ($48,074,000 of principal), DeepCurrents Investment Group LLC ($45,740,000 of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($40,132,000 of principal), MACKAY SHIELDS LLC ($33,922,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($33,092,000 of principal), Verition Fund Management LLC ($29,901,000 of principal), LAZARD ASSET MANAGEMENT LLC ($25,000,000 of principal), SILVERBACK ASSET MANAGEMENT LLC ($25,000,000 of principal), and D. E. Shaw & Co., Inc. ($21,350,000 of principal).
This table shows the top 59 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.